{"organizations": [], "uuid": "008f980cfd0a68fd6b99c8fdf1b65fef630b8d69", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/legal", "section_title": "Legal News | Reuters", "url": "https://www.reuters.com/article/ip-patent-simpleair/generic-drugmaker-urges-fed-circ-to-rehear-google-patent-case-fearing-vexatious-lawsuits-idUSL1N1S81KZ", "country": "US", "domain_rank": 408, "title": "Generic drugmaker urges Fed Circ to rehear Google patent case, fearing 'vexatious lawsuits'", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-05-02T04:44:00.000+03:00", "replies_count": 0, "uuid": "008f980cfd0a68fd6b99c8fdf1b65fef630b8d69"}, "author": "Jan Wolfe", "url": "https://www.reuters.com/article/ip-patent-simpleair/generic-drugmaker-urges-fed-circ-to-rehear-google-patent-case-fearing-vexatious-lawsuits-idUSL1N1S81KZ", "ord_in_thread": 0, "title": "Generic drugmaker urges Fed Circ to rehear Google patent case, fearing 'vexatious lawsuits'", "locations": [], "entities": {"persons": [{"name": "reddy", "sentiment": "none"}], "locations": [], "organizations": [{"name": "fed circ", "sentiment": "negative"}, {"name": "google", "sentiment": "negative"}, {"name": "simpleair inc", "sentiment": "none"}, {"name": "google llc", "sentiment": "none"}, {"name": "u.s. court of appeals for the federal circuit", "sentiment": "none"}, {"name": "laboratories ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "An Indian generic drug company on Monday urged a federal appeals court to reconsider a recent decision that revived a patent infringement case against Google LLC, saying the ruling could spur “vexatious lawsuits” by makers of brand-name pharmaceutical products.\nDr Reddy’s Laboratories Ltd asked the U.S. Court of Appeals for the Federal Circuit to rehear en banc its March 12 decision that a lawsuit brought against Google by licensing company SimpleAir Inc was not barred by the doctrine of claim preclusion.\nTo read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2FzxVbw\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "http://bit.ly/2FzxVbw", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://www.linkedin.com/company/10256858/", "https://instagram.com/reuters/"], "published": "2018-05-02T04:44:00.000+03:00", "crawled": "2018-05-02T07:32:15.001+03:00", "highlightTitle": ""}